Status:
COMPLETED
Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy
Lead Sponsor:
Orphelia Pharma
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Hospices Civils de Lyon
Conditions:
Infantile Spasms
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
The sponsor is developing a new paediatric formulation of vigabatrin to better adjust the dose to body weight and to limit waste of unused drug. The currently marketed vigabatrin (Sabril™) form only e...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with diagnosed infantile spasms (IS) or pharmacoresistant partial onset seizures (POS).
- Infants \> 1 month and \< 6 months; infants \> 6 months and \< 2 years; and children \> 2 years and \< 6 years.
- Patients under Sabril® or naive patients.
- Patients under a twice-a-day posology of Sabril® or patients for whom vigabatrin will be given twice daily.
- Non inclusion Criteria:
- Use of more than 2 other antiepileptic drugs as concomitant treatment (including steroids). Ketogenic diet can be in addition to these 2 other antiepileptic drugs.
- Subjects receiving vigabatrin through a gastric tube.
- Weight \< 1.750 Kgs.
- Any planned major surgery within the duration of the trial.
- Participation in any other clinical trial within 3 months prior to V1.
Exclusion
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT02220114
Start Date
May 1 2014
End Date
December 1 2016
Last Update
April 24 2018
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de neurologie pédiatrique - CHU
Amiens, France, 80054
2
Service de neurologie pédiatrique - CHU
Angers, France, 49033²
3
Service de neuropédiatrie - CHU Pellegrin Enfants
Bordeaux, France, 33076
4
Service de neurologie infantile - Hôpital Salengro
Lille, France, 59037